Nifty
Sensex
:
:
24834.85
81332.72
428.75 (1.76%)
1292.92 (1.62%)

Pharmaceuticals & Drugs - API

Rating :
76/99

BSE: 524558 | NSE: NEULANDLAB

7777.50
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  7650.00
  •  7811.00
  •  7590.80
  •  7702.00
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  12600
  •  976.38
  •  8650.00
  •  3286.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 10,755.42
  • 35.84
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 10,721.14
  • 0.17%
  • 8.39

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.72%
  • 5.11%
  • 27.05%
  • FII
  • DII
  • Others
  • 25.72%
  • 4.47%
  • 4.93%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 12.76
  • 15.36
  • 17.90

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 21.38
  • 35.34
  • 26.53

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 34.11
  • 79.26
  • 67.53

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 31.36
  • 28.13
  • 25.94

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.26
  • 2.92
  • 3.68

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.40
  • 13.82
  • 14.34

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
385.01
407.07
-5.42%
392.83
269.25
45.90%
417.75
293.71
42.23%
362.99
221.17
64.12%
Expenses
278.09
287.21
-3.18%
271.56
215.17
26.21%
280.26
224.41
24.89%
266.07
192.57
38.17%
EBITDA
106.92
119.86
-10.80%
121.27
54.08
124.24%
137.49
69.30
98.40%
96.92
28.60
238.88%
EBIDTM
27.77%
29.44%
30.87%
20.09%
32.91%
23.59%
26.70%
12.93%
Other Income
5.36
8.06
-33.50%
2.10
0.93
125.81%
3.05
0.24
1,170.83%
2.04
0.51
300.00%
Interest
3.61
4.29
-15.85%
3.74
2.75
36.00%
4.43
3.17
39.75%
2.21
2.86
-22.73%
Depreciation
16.46
13.47
22.20%
15.14
13.34
13.49%
14.51
13.17
10.17%
13.59
12.80
6.17%
PBT
92.20
110.16
-16.30%
104.48
38.94
168.31%
121.59
53.19
128.60%
83.16
13.46
517.83%
Tax
24.64
25.62
-3.83%
23.09
8.39
175.21%
32.35
14.73
119.62%
21.28
3.49
509.74%
PAT
67.56
84.54
-20.09%
81.39
30.55
166.42%
89.25
38.46
132.06%
61.88
9.97
520.66%
PATM
17.55%
20.77%
20.72%
11.35%
21.36%
13.10%
17.05%
4.51%
EPS
52.37
65.53
-20.08%
63.09
23.68
166.43%
69.18
29.81
132.07%
47.96
7.73
520.44%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
-
1,558.58
1,191.20
951.08
936.91
762.71
666.83
527.41
578.89
509.97
469.15
Net Sales Growth
-
30.84%
25.25%
1.51%
22.84%
14.38%
26.43%
-8.89%
13.51%
8.70%
 
Cost Of Goods Sold
-
577.29
478.23
422.14
438.42
380.20
366.24
238.37
262.90
253.46
243.99
Gross Profit
-
981.30
712.97
528.94
498.50
382.51
300.59
289.04
315.99
256.52
225.16
GP Margin
-
62.96%
59.85%
55.61%
53.21%
50.15%
45.08%
54.80%
54.59%
50.30%
47.99%
Total Expenditure
-
1,095.99
919.36
808.46
790.09
660.82
608.46
476.98
472.55
429.52
402.53
Power & Fuel Cost
-
48.72
48.62
42.21
39.21
32.75
26.81
25.95
25.78
22.24
22.53
% Of Sales
-
3.13%
4.08%
4.44%
4.19%
4.29%
4.02%
4.92%
4.45%
4.36%
4.80%
Employee Cost
-
257.06
201.79
182.47
149.74
123.56
110.46
102.99
92.74
65.38
51.81
% Of Sales
-
16.49%
16.94%
19.19%
15.98%
16.20%
16.56%
19.53%
16.02%
12.82%
11.04%
Manufacturing Exp.
-
107.79
86.94
89.16
77.10
64.84
50.10
55.54
44.90
39.31
43.56
% Of Sales
-
6.92%
7.30%
9.37%
8.23%
8.50%
7.51%
10.53%
7.76%
7.71%
9.28%
General & Admin Exp.
-
60.91
51.22
35.80
38.93
27.75
27.49
33.32
28.30
29.72
23.59
% Of Sales
-
3.91%
4.30%
3.76%
4.16%
3.64%
4.12%
6.32%
4.89%
5.83%
5.03%
Selling & Distn. Exp.
-
33.94
29.58
27.40
34.63
18.30
18.28
14.04
11.16
17.52
14.54
% Of Sales
-
2.18%
2.48%
2.88%
3.70%
2.40%
2.74%
2.66%
1.93%
3.44%
3.10%
Miscellaneous Exp.
-
10.29
22.99
9.28
12.08
13.42
9.08
6.77
6.78
1.89
14.54
% Of Sales
-
0.66%
1.93%
0.98%
1.29%
1.76%
1.36%
1.28%
1.17%
0.37%
0.54%
EBITDA
-
462.59
271.84
142.62
146.82
101.89
58.37
50.43
106.34
80.45
66.62
EBITDA Margin
-
29.68%
22.82%
15.00%
15.67%
13.36%
8.75%
9.56%
18.37%
15.78%
14.20%
Other Income
-
12.54
9.75
2.08
16.10
3.89
3.49
4.53
1.17
1.78
0.78
Interest
-
14.00
13.07
13.50
17.90
21.57
15.66
18.93
21.09
24.48
27.36
Depreciation
-
59.70
52.78
49.04
39.68
31.28
25.86
22.10
19.23
15.74
15.32
PBT
-
401.44
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
Tax
-
101.36
52.23
18.34
24.70
36.71
3.90
1.87
20.32
14.92
8.79
Tax Rate
-
25.25%
24.21%
22.32%
23.45%
69.37%
19.17%
13.42%
30.24%
35.52%
35.56%
PAT
-
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.33
15.94
PAT before Minority Interest
-
300.08
163.52
63.82
80.63
16.21
16.44
12.06
46.86
27.08
15.93
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.25
0.01
PAT Margin
-
19.25%
13.73%
6.71%
8.61%
2.13%
2.47%
2.29%
8.09%
5.36%
3.40%
PAT Growth
-
83.51%
156.22%
-20.85%
397.41%
-1.40%
36.32%
-74.26%
71.46%
71.46%
 
EPS
-
234.44
127.75
49.86
62.99
12.66
12.84
9.42
36.61
21.35
12.45

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
1,282.70
994.10
840.50
786.46
709.96
699.31
558.04
545.62
186.63
161.38
Share Capital
12.90
12.90
12.90
12.90
12.90
12.90
8.95
8.95
8.95
8.95
Total Reserves
1,269.80
981.20
827.60
773.56
697.06
686.41
238.24
225.81
177.68
152.42
Non-Current Liabilities
122.17
146.71
179.83
169.82
163.39
104.06
146.43
54.37
69.42
54.76
Secured Loans
44.92
74.25
104.25
88.13
77.37
60.72
103.49
29.81
33.40
21.22
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
12.00
12.00
Long Term Provisions
7.61
10.29
11.91
9.44
12.49
11.91
9.87
9.28
6.85
6.38
Current Liabilities
427.68
438.96
363.16
368.51
357.63
326.98
366.93
285.60
268.00
295.14
Trade Payables
191.96
171.01
117.38
152.13
115.56
119.68
124.29
85.92
83.86
111.81
Other Current Liabilities
234.01
244.87
152.35
158.75
71.63
57.45
41.83
47.18
55.02
31.28
Short Term Borrowings
0.00
11.16
92.21
56.98
168.17
149.06
199.20
151.08
123.63
145.80
Short Term Provisions
1.72
11.93
1.21
0.64
2.27
0.80
1.59
1.41
5.50
6.25
Total Liabilities
1,832.55
1,579.77
1,383.49
1,324.79
1,230.98
1,130.35
1,071.40
885.59
524.05
511.53
Net Block
804.64
738.19
747.70
696.94
622.76
511.69
445.01
435.74
138.77
123.07
Gross Block
1,072.98
950.36
913.27
826.48
714.33
575.44
483.45
454.74
291.78
263.65
Accumulated Depreciation
268.34
212.17
165.57
129.54
91.57
63.75
38.44
19.00
153.00
140.58
Non Current Assets
911.48
818.87
802.70
775.20
715.79
676.88
624.20
510.54
209.87
195.76
Capital Work in Progress
45.89
40.57
20.46
17.25
23.75
104.47
126.09
19.60
40.48
41.47
Non Current Investment
1.28
0.52
0.50
19.35
30.17
30.21
30.21
30.20
7.39
7.39
Long Term Loans & Adv.
40.47
20.24
14.38
41.67
35.81
30.51
22.66
24.79
22.73
23.83
Other Non Current Assets
0.17
0.00
0.00
0.00
3.30
0.00
0.22
0.22
0.50
0.00
Current Assets
921.08
760.89
580.79
549.59
515.19
453.47
447.19
375.04
314.19
315.77
Current Investments
0.00
0.00
3.38
6.46
7.50
7.50
7.50
7.50
0.00
0.00
Inventories
350.42
279.23
265.21
247.61
219.55
192.65
175.09
135.11
126.66
113.40
Sundry Debtors
373.53
361.77
234.33
217.73
189.89
164.02
193.92
181.11
119.11
128.85
Cash & Bank
116.80
59.10
20.36
19.40
46.98
37.84
17.26
12.49
9.71
6.98
Other Current Assets
80.33
13.70
11.52
8.84
51.27
51.46
53.43
38.83
58.70
66.53
Short Term Loans & Adv.
62.03
47.09
46.00
49.55
33.80
31.77
37.15
25.30
46.68
45.23
Net Current Assets
493.40
321.94
217.64
181.08
157.55
126.49
80.27
89.45
46.18
20.63
Total Assets
1,832.56
1,579.76
1,383.49
1,324.79
1,230.98
1,130.35
1,071.39
885.58
524.06
511.53

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
261.18
237.21
60.39
189.36
57.34
69.91
11.27
38.68
44.83
13.17
PBT
401.44
215.75
82.16
105.33
52.92
20.34
13.93
67.19
42.00
24.72
Adjustment
62.08
77.93
66.30
40.08
58.28
39.11
40.43
43.96
33.73
36.34
Changes in Working Capital
-90.73
-12.83
-67.58
49.22
-49.17
15.47
-40.02
-55.94
-19.17
-38.76
Cash after chg. in Working capital
372.78
280.84
80.88
194.63
62.03
74.91
14.35
55.20
56.56
22.30
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-111.60
-43.63
-20.49
-5.27
-4.68
-5.01
-3.08
-16.52
-11.73
-9.13
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-149.69
-61.50
-95.52
-84.42
-48.68
-77.23
-116.29
-42.11
-19.86
-14.13
Net Fixed Assets
-127.92
-60.11
-90.00
-105.64
-58.17
-70.35
-135.20
-142.08
-27.14
-12.02
Net Investments
-0.76
3.36
21.92
11.87
0.04
0.00
-0.01
-30.31
0.12
-0.03
Others
-21.01
-4.75
-27.44
9.35
9.45
-6.88
18.92
130.28
7.16
-2.08
Cash from Financing Activity
-69.28
-135.80
37.72
-113.66
-5.48
11.98
104.85
-0.09
-23.62
1.15
Net Cash Inflow / Outflow
42.21
39.92
2.59
-8.72
3.18
4.66
-0.17
-3.51
1.35
0.19
Opening Cash & Equivalents
45.42
5.09
2.44
11.20
7.94
3.29
3.44
6.97
0.81
0.62
Closing Cash & Equivalent
87.58
45.42
5.09
2.44
11.20
7.94
3.29
3.44
2.16
0.81

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
999.07
774.12
654.40
612.28
552.65
544.35
277.21
263.23
209.07
180.72
ROA
17.59%
11.04%
4.71%
6.31%
1.37%
1.49%
1.23%
6.65%
5.23%
3.20%
ROE
26.38%
17.84%
7.85%
10.79%
2.30%
3.48%
5.02%
22.34%
15.64%
11.24%
ROCE
33.51%
20.94%
9.44%
12.81%
7.85%
3.99%
4.07%
15.98%
18.57%
15.75%
Fixed Asset Turnover
1.54
1.28
1.09
1.22
1.18
1.26
1.13
1.57
1.86
1.82
Receivable days
86.10
91.33
86.74
79.40
84.68
97.96
129.34
93.22
87.45
94.81
Inventory Days
73.73
83.41
98.40
91.00
98.63
100.64
106.98
81.29
84.66
79.24
Payable days
114.75
110.05
116.52
111.44
65.43
75.72
82.06
67.03
85.01
92.70
Cash Conversion Cycle
45.08
64.68
68.63
58.96
117.88
122.89
154.27
107.48
87.10
81.35
Total Debt/Equity
0.06
0.12
0.28
0.22
0.37
0.33
1.30
0.82
0.98
1.17
Interest Cover
29.68
17.51
7.09
6.89
3.45
2.30
1.74
4.19
2.72
1.90

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.